Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 -estradiol or equine conjugated estrogen plus nomegestrol acetate

Author： Collette J.   Viethel P.   Dethor M.   Chevallier T.   Micheletti M.C.   Foidart J.M.   Reginster J.Y.  

Publisher： Elsevier

ISSN： 1297-9589

Source： Gynecology Obstetrique & Fertilite, Vol.31, Iss.5, 2003-05, pp. : 434-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period

By Nguyên-Pascal ML   Thomas JL   Bergougnoux L   Garnero P   Drapier-Faure E   Delmas PD  

Climacteric, Vol. 8, Iss. 2, 2005-06 ,pp. : 136-145

Informa Healthcare

Access to resources Recommend Favorite

What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone

By Simon J. A.  

Climacteric, Vol. 15, Iss. 1, 2012-04 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors

By Skouby S. O.   Sidelmann J. J.   Nilas L.   Gram J.   Jespersen J.  

Climacteric, Vol. 11, Iss. 6, 2008-01 ,pp. : 489-497

Informa Healthcare

Access to resources Recommend Favorite

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function

By Ågren Ulla M.   Anttila Marjatta   Mäenpää-Liukko Kristiina   Rantala Maija-Liisa   Rautiainen Hilkka   Sommer Werner F.   Mommers Ellen  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 6, 2011-12 ,pp. : 458-467

Informa Healthcare

Access to resources Recommend Favorite

Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone

By Mueck A. O.  

Climacteric, Vol. 15, Iss. 1, 2012-04 ,pp. : 11-17

Informa Healthcare

Access to resources Recommend Favorite